Rise in respiratory ailments leads to more introductions of inhalable medications

摘要

Each year, thousands more Americans are diagnosed with allergies, asthma, chronic obstructive pulmonary disease (COPD) and other respiratory ailments. Millions of people in the U.S. rely on treatments like Zetonna and other inhalable drugs, and on the drug packaging and delivery systems that make them possible.